NDAINJECTIONINJECTABLEPriority Review
Approved
Aug 1946
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
Priority Review
SOTRADECOL (sodium tetradecyl sulfate) by Viatris is clinical pharmacology sotradecol (sodium tetradecyl sulfate injection) is a sclerosing agent. Approved for the treatment of small uncomplicated varicose veins of the lower extremities. First approved in 1946.
Drug data last refreshed 11h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sotradecol (sodium tetradecyl sulfate) is a sclerosing agent administered by intravenous injection that obliterates small uncomplicated varicose veins of the lower extremities. It works by inducing intima inflammation and thrombus formation, leading to vein occlusion and fibrous tissue replacement. The treatment represents a minimally invasive alternative to surgical vein removal.
LOE Approaching
Mature product with approaching loss of exclusivity signals organizational focus on managed decline and transition planning rather than growth initiatives.
Mechanism of Action
CLINICAL PHARMACOLOGY Sotradecol (sodium tetradecyl sulfate injection) is a sclerosing agent. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration…
Career Relevance
Sotradecol currently shows zero linked job opportunities, indicating minimal career expansion potential and a legacy product within Viatris' portfolio. Career prospects on this brand are constrained by its mature stage, lack of clinical development, and approaching LOE.
Worked on SOTRADECOL at Viatris? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.